ARCHIVES

Groups Point to NCI Restrictions As Source Of Problems, Discuss Prioritizing Trials

This article is from The Cancer Letter archive.

Vol. 29 No. 28 | July 11, 2003

Download PDF Visit The Full Archive

Related Articles

Bills Would Give FDA Authority to Approve Generic Biotech Drugs.

February 16, 2007

Genetics Research Is Prevalent In Central Europe as Scientists Seek Answers To Related Questions

August 16, 1991

Tobacco Control In The States Can Reduce Use, NCPB Says.

February 18, 2000

Conference Split Difference, NCI Gets $1.075 Billion

October 21, 1983

Chemo+Radiation Preserves Voice, RTOG Study Finds

December 26, 2003

IVAX Agreement With Rival BMS Appears To Buttress BMS control of Paclitaxel

November 26, 1999